Zeo ScientifiX Past Earnings Performance
Past criteria checks 0/6
Zeo ScientifiX's earnings have been declining at an average annual rate of -12.7%, while the Biotechs industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 25.3% per year.
Key information
-12.7%
Earnings growth rate
4.6%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | 25.3% |
| Return on equity | n/a |
| Net Margin | -123.6% |
| Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Zeo ScientifiX makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 5 | -6 | 10 | 0 |
| 31 Oct 23 | 5 | -7 | 11 | 0 |
| 31 Jul 23 | 5 | -9 | 13 | 0 |
| 30 Apr 23 | 5 | -10 | 14 | 0 |
| 31 Jan 23 | 6 | -10 | 15 | 0 |
| 31 Oct 22 | 6 | -9 | 15 | 0 |
| 31 Jul 22 | 7 | -7 | 13 | 0 |
| 30 Apr 22 | 6 | -6 | 12 | -1 |
| 31 Jan 22 | 6 | -6 | 12 | 0 |
| 31 Oct 21 | 6 | -13 | 18 | 0 |
| 31 Jul 21 | 5 | -17 | 21 | 0 |
| 30 Apr 21 | 4 | -21 | 24 | 1 |
| 31 Jan 21 | 4 | -20 | 23 | 0 |
| 31 Oct 20 | 3 | -13 | 15 | 0 |
| 31 Jul 20 | 3 | -8 | 10 | 0 |
| 30 Apr 20 | 2 | -3 | 5 | 0 |
| 31 Jan 20 | 2 | -2 | 4 | 0 |
| 31 Oct 19 | 2 | -2 | 3 | 0 |
| 31 Jul 19 | 1 | -1 | 4 | 0 |
| 30 Apr 19 | 1 | -1 | 2 | 0 |
| 31 Jan 19 | 1 | -4 | 5 | 0 |
| 31 Oct 18 | 1 | -3 | 5 | 0 |
| 31 Jul 18 | 1 | -4 | 5 | 0 |
| 30 Apr 18 | 1 | -5 | 6 | 0 |
| 31 Jan 18 | 1 | -5 | 6 | 0 |
| 31 Oct 17 | 1 | -9 | 9 | 0 |
| 31 Jul 17 | 0 | -8 | 8 | 0 |
| 30 Apr 17 | 0 | -8 | 8 | 0 |
| 31 Jan 17 | 0 | -5 | 5 | 0 |
| 31 Oct 16 | 0 | -1 | 1 | 0 |
| 31 Jul 16 | 0 | -1 | 1 | 0 |
| 30 Apr 16 | 0 | -1 | 1 | 0 |
| 31 Jan 16 | 0 | -1 | 1 | 0 |
| 31 Oct 15 | 0 | -1 | 1 | 0 |
| 31 Jul 15 | 0 | 0 | 0 | 0 |
| 30 Apr 15 | 0 | 0 | 0 | 0 |
| 31 Jan 15 | 0 | 0 | 0 | 0 |
| 31 Oct 14 | 0 | 0 | 0 | 0 |
| 31 Jul 14 | 0 | 0 | 0 | 0 |
| 30 Apr 14 | 0 | 0 | 0 | 0 |
| 31 Jan 14 | 0 | 0 | 0 | 0 |
| 31 Oct 13 | 0 | 0 | 0 | 0 |
| 31 Jul 13 | 0 | 0 | 0 | 0 |
| 30 Apr 13 | 0 | 0 | 0 | 0 |
Quality Earnings: ZEOX is currently unprofitable.
Growing Profit Margin: ZEOX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZEOX is unprofitable, and losses have increased over the past 5 years at a rate of 12.7% per year.
Accelerating Growth: Unable to compare ZEOX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZEOX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: ZEOX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.